Literature DB >> 1999812

Guillain-Barré syndrome following severe exertion.

A A Adogu1.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1999812      PMCID： PMC1293106          DOI： 10.1177/014107689108400223

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  9 in total

1.  Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies.

Authors:  R P Lisak; M Mitchell; B Zweiman; E Orrechio; A K Asbury
Journal:  Ann Neurol       Date:  1977-01       Impact factor: 10.422

Review 2.  Exercise and the immune system.

Authors:  L Fitzgerald
Journal:  Immunol Today       Date:  1988-11

Review 3.  Autoimmunity: polyclonal activation or antigen induction?

Authors:  R Dziarski
Journal:  Immunol Today       Date:  1988-11

4.  Patterns of conduction failure in the Guillain-Barré syndrome.

Authors:  F G van der Meché; J Meulstee; M Vermeulen; A Kievit
Journal:  Brain       Date:  1988-04       Impact factor: 13.501

5.  Limited relapse in Guillain-Barré syndrome after plasma exchange.

Authors:  A E Ropper; J W Albert; R Addison
Journal:  Arch Neurol       Date:  1988-03

6.  Acute inflammatory polyneuropathy.

Authors:  R A Hughes
Journal:  Br J Hosp Med       Date:  1978-12

7.  Seizures induced by exercise.

Authors:  A O Ogunyemi; M R Gomez; D W Klass
Journal:  Neurology       Date:  1988-04       Impact factor: 9.910

8.  Guillain-Barré syndrome following acute head trauma.

Authors:  R Duncan; P G Kennedy
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

9.  Diagnostic considerations in Guillain-Barré syndrome.

Authors:  A K Asbury
Journal:  Ann Neurol       Date:  1981       Impact factor: 10.422
  9 in total
  1 in total

1.  Bickerstaff brainstem encephalitis after heat stroke.

Authors:  Akiyuki Uzawa; Masahiro Mori; Noriko Tamura; Hirokatsu Takahashi; Hiroyuki Hirasawa; Takamichi Hattori; Satoshi Kuwabara
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.